LivLyme Foundation Founder Olivia Goodreau to Discuss Perils of Lyme Disease in Free Webinar Hosted by Industry-Leading Quidel Corporation
August 10 2021 - 9:00AM
Business Wire
Olivia Goodreau, who founded the LivLyme Foundation at 12 years
old and has since become a widely respected advocate and national
spokeswoman for Lyme disease prevention and treatment, will discuss
her “journey with Lyme” and the importance of early testing as part
of a webinar to be held Thursday, Aug. 19. The webinar is the
latest in an ongoing series sponsored by Quidel, the
California-based diagnostic health care manufacturer known for
successfully developing rapid diagnostic health solutions.
Webinar Registration
The free online educational
program will take place Aug. 19 at noon EDT. Registration is
available now at
https://education.quidel.com/registration/2580/1/r/LD-1. You may
attend the webinar by accessing the same link on or after Aug. 19
at noon EDT.
Now 16 years old, Goodreau founded the LivLyme Foundation in
2017 to help raise money for individuals who cannot afford their
Lyme medication or doctors’ visits and to fund research to find a
cure for Lyme and tick-borne diseases. She has since awarded 54
grants to children and adults ages 2-21 along with four grants to
top universities to fund tick-borne disease research. Goodreau is
also the inventor of TickTracker, the free global app that has over
50,000 users in multiple languages worldwide. TickTracker was
selected by the U.S. Department of Health and Human Services as the
“top tech tool” that is solving global health problems, beating out
Oracle and IBM, among others.
As part of the webinar, Goodreau will discuss her journey with
Lyme, including when she became ill, the number of physicians she
visited, how she was diagnosed and her passion for the importance
of early testing. She will also discuss her work on the “public
stage,” having presented TickTracker at the White House and having
met with countless members of Congress, celebrities, scientists and
governmental agencies to educate and spread awareness about
tick-borne diseases.
Goodreau’s webinar presentation is particularly relevant today
as Lyme disease is on the rise to record numbers throughout the
country and has the potential to affect as many as 476,000 citizens
before the year is out. For accurate and fast testing, more and
more clinicians are turning to the Sofia® 2 Lyme FIA by Quidel.
This revolutionary test provides the patient and physician with
indicative results within 15 minutes, as opposed to days, which has
historically been the norm (and during which time organisms can
spread and become systemic). It can be performed in the privacy of
a doctor’s office, local clinic or even by a nurse at a children’s
summer camp; and it is the only test that can get results from a
simple finger prick of blood.
Among those expected to attend the free Aug. 19 webinar are
physicians; allied health professionals; health researchers; and
representatives of physician offices, laboratories, urgent care
centers, patient advocacy associations and others interested in the
subject.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of
diagnostic solutions at the point of care, delivering a continuum
of rapid testing technologies that further improve the quality of
health care throughout the globe. An innovator for over 40 years in
the medical device industry, Quidel pioneered the first
point-of-care test for influenza in 1999 and was the first to
market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted
brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®,
Quidel’s comprehensive product portfolio includes tests for a wide
range of infectious diseases, cardiac and autoimmune biomarkers, as
well as a host of products to detect COVID-19. Quidel’s mission is
to provide patients with immediate and frequent access to highly
accurate, affordable testing for the good of our families, our
communities and the world. For more information about Quidel, visit
quidel.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210810005457/en/
Jim Yeager 818-264-6812 (mobile) jim@breakwhitelight.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024